Department of Oncology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.
Biomed Pharmacother. 2022 Sep;153:113490. doi: 10.1016/j.biopha.2022.113490. Epub 2022 Aug 1.
The transcription factor zinc finger E-box binding homeobox 1 (ZEB1) is a critical inducer of epithelial mesenchymal transformation (EMT) and plays a robust role in tumor metastasis. It can promote not only the movement and diffusion of tumor cells but also cell stemness, treatment resistance, tumor metastasis and immune escape. The expression of ZEB1 is strictly regulated by a variety of pretranscriptional and posttranscriptional signaling pathways and molecules. Increasing evidence indicates that protein modifications such as methylation and acetylation of ZEB1 can also affect tumor metastasis. More importantly, ZEB1 induces immunosuppressive cells and chemokines into the tumor microenvironment (TME), leading to the formation of a tumor immunosuppressive microenvironment. This review summarizes the regulatory factors involved in ZEB1 expression and its important role. The areas of research covered in this review contribute to providing new thoughts and new treatment insights for targeted ZEB1 therapy of malignant tumors.
转录因子锌指 E 盒结合同源盒 1(ZEB1)是上皮间质转化(EMT)的关键诱导因子,在肿瘤转移中发挥着强大的作用。它不仅可以促进肿瘤细胞的运动和扩散,还可以促进细胞干性、治疗耐药性、肿瘤转移和免疫逃逸。ZEB1 的表达受到多种转录前和转录后信号通路和分子的严格调控。越来越多的证据表明,ZEB1 的蛋白质修饰,如甲基化和乙酰化,也可以影响肿瘤转移。更重要的是,ZEB1 将免疫抑制细胞和趋化因子诱导到肿瘤微环境(TME)中,导致肿瘤免疫抑制微环境的形成。本综述总结了参与 ZEB1 表达调控的调节因子及其重要作用。本综述涵盖的研究领域为恶性肿瘤的靶向 ZEB1 治疗提供了新的思路和新的治疗见解。